FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3045857570> ?p ?o ?g. }

• W3045857570 endingPage "2353" @default.
• W3045857570 startingPage "2345" @default.
• W3045857570 abstract "Objective: To investigate the mechanism of sovereign medicines in Sanren Decoction on coronavirus disease 2019 (COVID-19) through network pharmacology and molecular docking methods. Methods: The main active ingredients of sovereign medicines in Sanren Decoction (Armeniacae Semen Amarum, Amomun kravanh Pierre ex Gagnep, and Coicis Semen) were obtained and screened from by TCMSP and TCMID V2.0, combined with related research. Using UniPort database to query the target proteins corresponding to the active ingredients, then a component-target network was constructed by Cytoscape 3.7.2. PPI network was constructed through the STRING website, and cytoHubba was used to analysis the key subnetworks. CTD database was used to analyze GO and KEGG enrichment of the active ingredient target proteins of Sanren Decoction. Using the active ingredients of sovereign medicines in Sanren Decoction and related chemical drugs such as lopinavir as ligands, molecular docking with the SARS-CoV-2 3CL hydrolase was performed through the CB-Dock website. Results: Sovereign medicines in Sanren Decoction had 39 active ingredients, corresponding to 168 target proteins. The GO enrichment analysis obtained 25 biological processes (BP) items, 14 related items of cell composition (CC), and two molecular function (MF) item, respectively. KEGG enrichment screened 36 signaling pathways such as innate immune system, cytokine signaling in immune system, signaling by interleukins. The molecular docking results suggested that the active ingredients of mairin, ziziphin_qt, and oleanolic acid of sovereign medicines in Sanren Decoction had good binding energy with SARS-CoV-2 3CL hydrolase, and the Vina score of them were similar to those of lopinavir (the 3CLpro inhibitor) and remdesivir (RNA-dependent RNA polymerase inhibitor). Conclusion: Sovereign medicines in Sanren Decoction may participate in inflammation-related signaling pathways by regulating inflammatory factors, regulating multiple physiological processes of the disease with multi-components, multi-targets, and multi-pathways. It plays a certain intervention role in the treatment of COVID-19 and its active ingredients have potential resistance to SARS-CoV-2." @default.
• W3045857570 created "2020-08-03" @default.
• W3045857570 creator A5011611155 @default.
• W3045857570 creator A5015367628 @default.
• W3045857570 creator A5037422943 @default.
• W3045857570 creator A5038179910 @default.
• W3045857570 creator A5056766584 @default.
• W3045857570 creator A5059325717 @default.
• W3045857570 creator A5065636937 @default.
• W3045857570 creator A5084208504 @default.
• W3045857570 date "2020-05-12" @default.
• W3045857570 modified "2023-09-27" @default.
• W3045857570 title "Mechanism of sovereign medicines in Sanren Decoction on COVID-19 based on network pharmacology and molecular docking/ 网络药理学及分子对接法探讨三仁汤主要成分对新型冠状病毒肺炎(COVID-19)的机制研究" @default.
• W3045857570 hasPublicationYear "2020" @default.
• W3045857570 type Work @default.
• W3045857570 sameAs 3045857570 @default.
• W3045857570 citedByCount "0" @default.
• W3045857570 crossrefType "journal-article" @default.
• W3045857570 hasAuthorship W3045857570A5011611155 @default.
• W3045857570 hasAuthorship W3045857570A5015367628 @default.
• W3045857570 hasAuthorship W3045857570A5037422943 @default.
• W3045857570 hasAuthorship W3045857570A5038179910 @default.
• W3045857570 hasAuthorship W3045857570A5056766584 @default.
• W3045857570 hasAuthorship W3045857570A5059325717 @default.
• W3045857570 hasAuthorship W3045857570A5065636937 @default.
• W3045857570 hasAuthorship W3045857570A5084208504 @default.
• W3045857570 hasConcept C104317684 @default.
• W3045857570 hasConcept C142724271 @default.
• W3045857570 hasConcept C150194340 @default.
• W3045857570 hasConcept C152724338 @default.
• W3045857570 hasConcept C159110408 @default.
• W3045857570 hasConcept C185592680 @default.
• W3045857570 hasConcept C190409667 @default.
• W3045857570 hasConcept C204787440 @default.
• W3045857570 hasConcept C2778858181 @default.
• W3045857570 hasConcept C2779446555 @default.
• W3045857570 hasConcept C2780035454 @default.
• W3045857570 hasConcept C2987395477 @default.
• W3045857570 hasConcept C41685203 @default.
• W3045857570 hasConcept C45904493 @default.
• W3045857570 hasConcept C55493867 @default.
• W3045857570 hasConcept C556039675 @default.
• W3045857570 hasConcept C70721500 @default.
• W3045857570 hasConcept C71924100 @default.
• W3045857570 hasConcept C86803240 @default.
• W3045857570 hasConcept C98274493 @default.
• W3045857570 hasConceptScore W3045857570C104317684 @default.
• W3045857570 hasConceptScore W3045857570C142724271 @default.
• W3045857570 hasConceptScore W3045857570C150194340 @default.
• W3045857570 hasConceptScore W3045857570C152724338 @default.
• W3045857570 hasConceptScore W3045857570C159110408 @default.
• W3045857570 hasConceptScore W3045857570C185592680 @default.
• W3045857570 hasConceptScore W3045857570C190409667 @default.
• W3045857570 hasConceptScore W3045857570C204787440 @default.
• W3045857570 hasConceptScore W3045857570C2778858181 @default.
• W3045857570 hasConceptScore W3045857570C2779446555 @default.
• W3045857570 hasConceptScore W3045857570C2780035454 @default.
• W3045857570 hasConceptScore W3045857570C2987395477 @default.
• W3045857570 hasConceptScore W3045857570C41685203 @default.
• W3045857570 hasConceptScore W3045857570C45904493 @default.
• W3045857570 hasConceptScore W3045857570C55493867 @default.
• W3045857570 hasConceptScore W3045857570C556039675 @default.
• W3045857570 hasConceptScore W3045857570C70721500 @default.
• W3045857570 hasConceptScore W3045857570C71924100 @default.
• W3045857570 hasConceptScore W3045857570C86803240 @default.
• W3045857570 hasConceptScore W3045857570C98274493 @default.
• W3045857570 hasIssue "51" @default.
• W3045857570 hasLocation W30458575701 @default.
• W3045857570 hasOpenAccess W3045857570 @default.
• W3045857570 hasPrimaryLocation W30458575701 @default.
• W3045857570 hasRelatedWork W3016646294 @default.
• W3045857570 hasRelatedWork W3029220235 @default.
• W3045857570 hasRelatedWork W3029688405 @default.
• W3045857570 hasRelatedWork W3031402983 @default.
• W3045857570 hasRelatedWork W3032053047 @default.
• W3045857570 hasRelatedWork W3035021648 @default.
• W3045857570 hasRelatedWork W3038603403 @default.
• W3045857570 hasRelatedWork W3048211722 @default.
• W3045857570 hasRelatedWork W3083246393 @default.
• W3045857570 hasRelatedWork W3083327398 @default.
• W3045857570 hasRelatedWork W3093148431 @default.
• W3045857570 hasRelatedWork W3102016714 @default.
• W3045857570 hasRelatedWork W3116575476 @default.
• W3045857570 hasRelatedWork W3121804669 @default.
• W3045857570 hasRelatedWork W3133997200 @default.
• W3045857570 hasRelatedWork W3139200185 @default.
• W3045857570 hasRelatedWork W3172802844 @default.
• W3045857570 hasRelatedWork W3184835786 @default.
• W3045857570 hasRelatedWork W3199682450 @default.
• W3045857570 hasRelatedWork W3211921570 @default.
• W3045857570 hasVolume "9" @default.
• W3045857570 isParatext "false" @default.
• W3045857570 isRetracted "false" @default.
• W3045857570 magId "3045857570" @default.
• W3045857570 workType "article" @default.